Skip to main content
. 2022 Mar 8;10:839374. doi: 10.3389/fbioe.2022.839374

TABLE 4.

Statistical evaluation of the N-glycan analysis peak profiles of bamlanivimab.

Peak ID GU Exoglycosidase sequencing - response Migration time (min) %Area
NANase GALase HEXase Aliquot #1 Aliquot #2 Aliquot #3 Median Std.Dev. %RSD Aliquot #1 Aliquot #2 Aliquot #3 Median Std.Dev. %RSD
1 M4 5.74 10.28 10.26 10.25 10.26 0.01 0.13 0.19 0.19 0.19 0.19 0.00 2.17
2 FA2G1S1 5.92 X 10.40 10.38 10.38 10.39 0.01 0.12 0.13 0.13 0.13 0.13 0.00 1.26
3 A2G2S1 6.18 x 10.57 10.55 10.55 10.56 0.01 0.12 0.12 0.11 0.11 0.11 0.00 4.37
4 A2 6.56 x 10.81 10.79 10.78 10.79 0.01 0.12 4.71 4.81 4.86 4.79 0.08 1.64
5 M5 6.67 10.87 10.85 10.85 10.85 0.01 0.12 0.41 0.42 0.43 0.42 0.01 2.81
6 A2B 6.89 x 11.02 11.00 10.99 11.00 0.01 0.13 0.32 0.32 0.29 0.31 0.02 5.52
7 FA2 7.49 x 11.38 11.35 11.35 11.36 0.01 0.12 73.51 73.32 73.74 73.52 0.21 0.28
8 M6 7.59 11.44 11.42 11.42 11.42 0.01 0.09 0.70 0.66 0.67 0.68 0.02 2.63
9 N/A 7.76 x 11.54 11.52 11.51 11.52 0.01 0.12 1.65 1.71 1.64 1.66 0.04 2.26
10 A2G1 7.90 x 11.63 11.61 11.61 11.61 0.01 0.11 0.23 0.23 0.21 0.23 0.01 5.19
11 A2B[6]G1 8.01 x 11.69 11.67 11.67 11.68 0.01 0.12 0.23 0.24 0.23 0.23 0.00 1.45
12 N/A 8.26 x 11.84 11.82 11.82 11.83 0.01 0.12 0.94 0.95 0.92 0.93 0.02 1.84
13 FA2[6]G1 8.53 x 12.00 11.98 11.97 11.98 0.01 0.11 11.67 11.73 11.55 11.65 0.10 0.82
14 FA2[3]G1 8.85 x 12.20 12.17 12.17 12.18 0.01 0.12 4.22 4.21 4.12 4.18 0.05 1.24
15 FA2G2 9.87 x 12.81 12.78 12.78 12.79 0.01 0.11 0.99 0.98 0.93 0.96 0.03 3.40
Total afucosylated (incl. high mannose) peaks (%) 9.56 %RSD median - all peaks (>0.01%) 0.12 %RSD median - all peaks (>0.01%) 2.46
Total terminal galactosylated peaks (%) 17.25 %RSD median - %area below 1% 0.12 %RSD median - %area below 1% 3.06
Total high mannose peaks (%) 1.29 %RSD median - %area between 1 and 5% 0.12 %RSD median - %area between 1 and 5% 1.71
Total sialylated peaks (%) 0.55 %RSD median - %area over 5% 0.12 %RSD median - %area over 5% 0.55